Implementing FDA Guidance Using Next-Gen Approaches to Representative Clinical Trial Recruitment & Design

At SCOPE 2025, Ligthship CEO David MacMurchy and Pfizer Head of Strategic Solutions Tim Joy discuss the industry challenge and where more needs to be done, including:

  • Representation in research remains unresolved
  • Intentional community engagement offers promising results
  • The Sponsor perspective
  • Approaches incorporating multiple innovative strategies in the clinical trial model
  • Case studies where Lightship and Pfizer worked together

Share: